Skip Navigation


IJE Advance Access originally published online on September 29, 2008
International Journal of Epidemiology 2009 38(1):276-286; doi:10.1093/ije/dyn179
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
38/1/276    most recent
dyn179v3
dyn179v2
dyn179v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Int. J. Epidemiol.
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Thorlund, K.
Right arrow Articles by Gluud, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thorlund, K.
Right arrow Articles by Gluud, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2008; all rights reserved.

Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?

Kristian Thorlund1,*, P J Devereaux2, Jørn Wetterslev1, Gordon Guyatt2, John P A Ioannidis3, Lehana Thabane4, Lise-Lotte Gluud1, Bodil Als-Nielsen1 and Christian Gluud1

1 Copenhagen Trial Unit, Center for Clinical Intervention Research, Copenhagen University Hospital, Department 3344, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
2 Faculty of Health Sciences, Department of Clinical Epidemiology and Biostatistics, McMaster University, CLARITY, L8N 3Z5 Hamilton, Ontario, Canada.
3 Department of Hygiene and Epidemiology, Clinical and Molecular Epidemiology Unit, University of Ioannina School of Medicine, Ioannina, 45110, Greece.
4 Faculty of Health Sciences, Department of Clinical Epidemiology Centre for Evaluation of Medicines, McMaster University, Biostatistics/FSORC, St Joseph's Healthcare Hamilton, Hamilton ON L8N 4A6, Ontario, Canada.

* Corresponding author. Copenhagen Trial Unit, Center for Clinical Intervention Research, Copenhagen University Hospital, Department 3344, Blegdamsvej 9, DK-2100 Copenhagen, Denmark. E-mail: kthorlund{at}ctu.rh.dk


   Abstract

Background Results from apparently conclusive meta-analyses may be false. A limited number of events from a few small trials and the associated random error may be under-recognized sources of spurious findings. The information size (IS, i.e. number of participants) required for a reliable and conclusive meta-analysis should be no less rigorous than the sample size of a single, optimally powered randomized clinical trial. If a meta-analysis is conducted before a sufficient IS is reached, it should be evaluated in a manner that accounts for the increased risk that the result might represent a chance finding (i.e. applying trial sequential monitoring boundaries).

Methods We analysed 33 meta-analyses with a sufficient IS to detect a treatment effect of 15% relative risk reduction (RRR). We successively monitored the results of the meta-analyses by generating interim cumulative meta-analyses after each included trial and evaluated their results using a conventional statistical criterion ({alpha} = 0.05) and two-sided Lan-DeMets monitoring boundaries. We examined the proportion of false positive results and important inaccuracies in estimates of treatment effects that resulted from the two approaches.

Results Using the random-effects model and final data, 12 of the meta-analyses yielded P > {alpha} = 0.05, and 21 yielded P ≤ {alpha} = 0.05. False positive interim results were observed in 3 out of 12 meta-analyses with P > {alpha} = 0.05. The monitoring boundaries eliminated all false positives. Important inaccuracies in estimates were observed in 6 out of 21 meta-analyses using the conventional P ≤ {alpha} = 0.05 and 0 out of 21 using the monitoring boundaries.

Conclusions Evaluating statistical inference with trial sequential monitoring boundaries when meta-analyses fall short of a required IS may reduce the risk of false positive results and important inaccurate effect estimates.


Keywords Meta-analysis, information size, monitoring boundaries, spurious inferences

Accepted 30 July 2008


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in Int. J. Epidemiol.:

Apparently conclusive meta-analyses may be inconclusive—Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses
Jesper Brok, Kristian Thorlund, Jørn Wetterslev, and Christian Gluud
Int. J. Epidemiol. 2009 38: 287-298. [Abstract] [FREE Full Text]  



This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
M. Monami, N. Marchionni, and E. Mannucci
Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials
Eur. J. Endocrinol., June 1, 2009; 160(6): 909 - 917.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
J. Brok, K. Thorlund, J. Wetterslev, and C. Gluud
Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses
Int. J. Epidemiol., February 1, 2009; 38(1): 287 - 298.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
E. Nuesch and P. Juni
Commentary: Which meta-analyses are conclusive?
Int. J. Epidemiol., February 1, 2009; 38(1): 298 - 303.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.